Extended Anticoagulation Therapy With Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Different Performance Status Scores: Insights From the ONCO PE Randomized Trial. [PDF]
J Am Heart AssocXiong W +14 more
europepmc +1 more source
Scoping review of apixaban and rivaroxaban dosing for atrial fibrillation and venous thromboembolism in advanced chronic kidney disease. [PDF]
Int J Clin PharmGillis S +9 more
europepmc +1 more source
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026. [PDF]
Lancet Reg Health EurBecker S.
europepmc +1 more source
DOAC Score Versus HAS-BLED and ORBIT for Predicting Bleeding Events in Atrial Fibrillation on Direct Oral Anticoagulants. [PDF]
Clin CardiolGuo Y, Zhu W, Ren Q.
europepmc +1 more source
Concurrent Acute Coronary Syndrome and Pulmonary Embolism in a Patient With Gastric Malignancy: A Diagnostic and Therapeutic Challenge. [PDF]
CureusTurnbull C, Elshenawy H.
europepmc +1 more source
Misdiagnosis of rivaroxaban-associated multiple intracranial hemorrhages as intracranial metastatic tumor: a case report. [PDF]
Front Med (Lausanne)Xu F, Liu Q, Hua S, Yang S.
europepmc +1 more source
Accidental Rivaroxaban Intoxication in a 25-month-old Child Monitored by Thromboelastography: A Case Report. [PDF]
Kobe J Med SciNakanishi K +8 more
europepmc +1 more source
Bothrops jararaca snake venom: A reappraisal of its coagulant activity in humans, mice, and rats. [PDF]
PLoS Negl Trop DisTorres AV +7 more
europepmc +1 more source
Economic evaluation of direct oral anticoagulants (DOACs) for venous thromboembolism with different etiologies: a systematic review. [PDF]
Health Econ RevKarimi F +4 more
europepmc +1 more source
Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers. [PDF]
Res Pract Thromb HaemostKumar R +6 more
europepmc +1 more source